Literature DB >> 7480551

Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital: experimental studies and literature review.

A Agmo1, A Galvan, A Heredia, M Morales.   

Abstract

The role of opioid systems in the anticonflict effect of chlordiazepoxide, diazepam and pentobarbital was evaluated with a modified Vogel procedure. First, morphine, ineffective by itself, was combined with subeffective or marginally effective doses of the benzodiazepines in order to detect possible potentiation. However, the combined treatment reduced licking in the Vogel procedure as well as in a licking test where no shock was administered. Several doses of the benzodiazepines and pentobarbital were then administered in combination with several doses of the opiate antagonist naloxone. A dose-dependent inhibition of anticonflict effect was obtained. In an additional experiment, it was shown that naloxone blocked the effects of diazepam in the elevated plus-maze procedure. Motor deficiencies, as evaluated with a rotarod test, produced by the benzodiazepines and pentobarbital could not be antagonized by naloxone. It is concluded that opioids are important for the anticonflict but not for the motor effects of these drugs. An analysis of published studies concerning the interaction of opioids and benzodiazepines in several procedures supposed to reflect anxiolytic effects shows that the inhibition obtained with naloxone is reliable and not procedure specific. The mechanisms by which opiate antagonists produce this inhibition of anticonflict activity are not known. It is tentatively suggested that opioid activation associated with stress may be a necessary component of anxiolysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480551     DOI: 10.1007/bf02246192

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  A simple and reliable conflict procedure for testing anti-anxiety agents.

Authors:  J R Vogel; B Beer; D E Clody
Journal:  Psychopharmacologia       Date:  1971

2.  Diazepam effects on striatal met-enkephalin levels following long-term pharmacological manipulations.

Authors:  M Wüster; T Duka; A Herz
Journal:  Neuropharmacology       Date:  1980-06       Impact factor: 5.250

3.  Naloxone and chlordiazepoxide: effects on acquisition and performance of signalled punishment.

Authors:  G Tripp; N McNaughton
Journal:  Pharmacol Biochem Behav       Date:  1991-01       Impact factor: 3.533

4.  Blockade of the development of analgesic tolerance to morphine by psychological stress through benzodiazepine receptor mediated mechanism.

Authors:  S Tokuyama; M Takahashi; H Kaneto
Journal:  Jpn J Pharmacol       Date:  1989-11

5.  Brain and serum levels of naloxone following peripheral administration.

Authors:  F S Tepperman; M Hirst; P Smith
Journal:  Life Sci       Date:  1983-09-12       Impact factor: 5.037

6.  Naloxone fails to block the effects of chlordiazepoxide on acquisition and performance of successive discrimination.

Authors:  G Tripp; N McNaughton
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 7.  Dopamine and antianxiety activity.

Authors:  D P Taylor; L A Riblet; H C Stanton; A S Eison; M S Eison; D L Temple
Journal:  Pharmacol Biochem Behav       Date:  1982       Impact factor: 3.533

8.  Diazepam use among methadone maintenance patients: patterns and dosages.

Authors:  M L Stitzer; R R Griffiths; A T McLellan; J Grabowski; J W Hawthorne
Journal:  Drug Alcohol Depend       Date:  1981-11       Impact factor: 4.492

  8 in total
  7 in total

1.  Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes.

Authors:  R J Rodgers; R Augar; N Berryman; C J Hansom; M L O'Mahony; R M Palmer; A Stevens; A J Tallett
Journal:  Psychopharmacology (Berl)       Date:  2006-06-27       Impact factor: 4.530

2.  Microinjection of naltrexone into the central, but not the basolateral, amygdala blocks the anxiolytic effects of diazepam in the plus maze.

Authors:  Paul R Burghardt; Marlene A Wilson
Journal:  Neuropsychopharmacology       Date:  2006-06       Impact factor: 7.853

3.  The role of delta opioid receptors in the anxiolytic actions of benzodiazepines.

Authors:  Stefany D Primeaux; Steven P Wilson; Alexander J McDonald; Franco Mascagni; Marlene A Wilson
Journal:  Pharmacol Biochem Behav       Date:  2006-11-15       Impact factor: 3.533

4.  Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation.

Authors:  Huiqun Wang; Saheem A Zaidi; Yan Zhang
Journal:  Bioorg Med Chem       Date:  2017-03-06       Impact factor: 3.641

5.  The flavonoid glycosides, myricitrin, gossypin and naringin exert anxiolytic action in mice.

Authors:  Sebastian P Fernandez; Michael Nguyen; Tin Thing Yow; Cindy Chu; Graham A R Johnston; Jane R Hanrahan; Mary Chebib
Journal:  Neurochem Res       Date:  2009-04-23       Impact factor: 3.996

6.  The role of amygdalar mu-opioid receptors in anxiety-related responses in two rat models.

Authors:  Marlene A Wilson; Lorain Junor
Journal:  Neuropsychopharmacology       Date:  2008-01-23       Impact factor: 7.853

Review 7.  Polydrug abuse: a review of opioid and benzodiazepine combination use.

Authors:  Jermaine D Jones; Shanthi Mogali; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-08-02       Impact factor: 4.492

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.